|
19.07.12
|
|
Novartis halten
|
Independent Research GmbH
|
|
19.07.12
|
|
Novartis buy
|
Sarasin Research
|
|
19.07.12
|
|
UBS underperform
|
Exane-BNP Paribas SA
|
|
19.07.12
|
|
Swisscom neutral
|
Nomura
|
|
19.07.12
|
|
ABB (Asea Brown Boveri) hold
|
ING
|
|
19.07.12
|
|
Logitech hold
|
Vontobel Research
|
|
19.07.12
|
|
UBS equal-weight
|
Morgan Stanley
|
|
19.07.12
|
|
ABB (Asea Brown Boveri) buy
|
Vontobel Research
|
|
19.07.12
|
|
UBS sell
|
Société Générale Group S.A. (SG)
|
|
19.07.12
|
|
Novartis hold
|
Vontobel Research
|
|
19.07.12
|
|
Novartis hold
|
Vontobel Research
|
|
19.07.12
|
|
Novartis buy
|
Société Générale Group S.A. (SG)
|
|
19.07.12
|
|
UBS hold
|
Vontobel Research
|
|
19.07.12
|
|
UBS halten
|
Independent Research GmbH
|
|
18.07.12
|
|
UBS buy
|
Citigroup Corp.
|
|
18.07.12
|
|
UBS buy
|
Citigroup Corp.
|
|
18.07.12
|
|
UBS neutral
|
Sarasin Research
|
|
18.07.12
|
|
UBS hold
|
Commerzbank Corp. & Markets
|
|
18.07.12
|
|
Logitech outperform
|
Exane-BNP Paribas SA
|
|
18.07.12
|
|
Novartis neutral
|
Exane-BNP Paribas SA
|
|
17.07.12
|
|
Novartis buy
|
Deutsche Bank AG
|
|
17.07.12
|
|
Roche buy
|
Deutsche Bank AG
|
|
17.07.12
|
|
Kühne + Nagel International neutral
|
UBS AG
|
|
17.07.12
|
|
Kühne + Nagel International buy
|
Nomura
|
|
17.07.12
|
|
Novartis buy
|
Société Générale Group S.A. (SG)
|
|
17.07.12
|
|
Novartis buy
|
UBS AG
|
|
17.07.12
|
|
Nestlé hold
|
ING
|
|
17.07.12
|
|
Kühne + Nagel International hold
|
Vontobel Research
|
|
17.07.12
|
|
ABB (Asea Brown Boveri) outperform
|
Sanford C. Bernstein and Co., Inc.
|
|
17.07.12
|
|
Zurich Insurance buy
|
Sarasin Research
|
|
16.07.12
|
|
Givaudan reduce
|
Nomura
|
|
16.07.12
|
|
ABB (Asea Brown Boveri) buy
|
Citigroup Corp.
|
|
16.07.12
|
|
Swisscom buy
|
Deutsche Bank AG
|
|
16.07.12
|
|
Kühne + Nagel International neutral
|
Sarasin Research
|
|
16.07.12
|
|
UBS underperform
|
Exane-BNP Paribas SA
|
|
16.07.12
|
|
Julius Bär buy
|
Sarasin Research
|
|
16.07.12
|
|
Kühne + Nagel International hold
|
Vontobel Research
|
|
16.07.12
|
|
UBS outperform
|
Keefe, Bruyette & Woods, Inc.
|
|
13.07.12
|
|
Swiss Re underperform
|
Banc of America Securities-Merrill Lynch
|
|
13.07.12
|
|
Novartis buy
|
Nomura
|